Get the Stockscreener App
3.635
0.69%
0.025
Savara Inc stock is traded at $3.635, with a volume of 141.96K.
It is up +0.69% in the last 24 hours and up +19.57% over the past month.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
See More
Previous Close:
$3.61
Open:
$3.61
24h Volume:
141.96K
Relative Volume:
0.11
Market Cap:
$626.53M
Revenue:
-
Net Income/Loss:
$-54.70M
P/E Ratio:
-11.02
EPS:
-0.33
Net Cash Flow:
$-51.36M
1W Performance:
-4.84%
1M Performance:
+19.57%
6M Performance:
+39.27%
1Y Performance:
-15.86%
1-Day Range:
$3.58
$3.66
1-Week Range:
$3.47
$3.915
52-Week Range:
$1.89
$4.70
Savara Inc Stock (SVRA) Company Profile
Name
Savara Inc
Sector
Industry
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX
Compare SVRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.625 | 623.94M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.03 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.64 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.77 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
749.25 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.84 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Nov-13-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-24 | Initiated | JMP Securities | Mkt Outperform |
| Nov-07-23 | Initiated | Guggenheim | Buy |
| May-16-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-31-23 | Downgrade | Jefferies | Buy → Hold |
| Mar-16-21 | Initiated | Piper Sandler | Overweight |
| Mar-15-21 | Initiated | Oppenheimer | Outperform |
| Jun-13-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-13-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-13-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Aug-13-18 | Resumed | ROTH Capital | Neutral |
| Jan-03-18 | Initiated | Ladenburg Thalmann | Buy |
| Sep-27-17 | Resumed | ROTH Capital | Buy |
| Sep-22-17 | Initiated | Jefferies | Buy |
| Sep-11-17 | Initiated | JMP Securities | Mkt Outperform |
View All
Savara Inc Stock (SVRA) Latest News
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA - WV News
Meme Stocks: Is Savara Inc. a cyclical or defensive stockPortfolio Return Summary & High Conviction Buy Zone Alerts - خودرو بانک
Fundamentals Check: Is Savara Inc impacted by rising ratesQuarterly Portfolio Summary & Technical Buy Zone Confirmation - خودرو بانک
Signal strength of Savara Inc. stock in tech scannersTreasury Yields & Daily Profit Focused Screening - newser.com
Levi & Korsinsky Moves to SueWallSt for Savara Inc. Investors That Lost Money - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Savara Inc. (SVRA) Investors To Inquire About Securities Fraud Class Action - Benzinga
Whale Trades: Why is Savara Inc stock going downEarnings Growth Summary & Safe Capital Allocation Plans - خودرو بانک
Targets Report: Can Savara Inc withstand a market correction2025 Key Highlights & Daily Profit Maximizing Tips - خودرو بانک
SVRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Savara Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Savara Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before November 7, 2025 to Discuss Your RightsSVRA - MarketScreener
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, - GlobeNewswire
Risk Recap: What’s the RSI of Savara Inc. stockQuarterly Market Summary & Expert Approved Momentum Trade Ideas - خودرو بانک
New Highs: Should I set a stop loss on Savara IncWeekly Market Summary & Free Community Supported Trade Ideas - خودرو بانک
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
What MACD and RSI say about Savara Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Exome Asset Management LLC Purchases 136,699 Shares of Savara Inc. $SVRA - MarketBeat
What earnings revisions data tells us about Savara Inc.Analyst Downgrade & Free High Return Stock Watch Alerts - newser.com
Savara (NASDAQ:SVRA) Shares Down 3.3%Time to Sell? - MarketBeat
Quantitative breakdown of Savara Inc. recent moveQuarterly Trade Report & Trade Opportunity Analysis Reports - newser.com
Savara Inc. stock prediction for this weekWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
Measuring Savara Inc.’s beta against major indicesWeekly Profit Report & Fast Moving Stock Watchlists - newser.com
Guggenheim Forecasts Strong Price Appreciation for Savara (NASDAQ:SVRA) Stock - MarketBeat
What to expect from Savara Inc. in the next 30 days2025 Price Targets & Daily Market Momentum Tracking - newser.com
Savara (NASDAQ:SVRA) Given New $8.00 Price Target at Oppenheimer - MarketBeat
Advanced analytics toolkit walkthrough for Savara Inc.Weekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire
Savara Increases Estimate of Autoimmune PAP Prevalence in U.S., Advances MOLBREEVI Toward FDA Resubmission - MSN
Savara Inc. (NASDAQ:SVRA) Receives $6.67 Consensus Price Target from Brokerages - MarketBeat
SVRA Class Action Alert: Robbins LLP Reminds Stockholders - GlobeNewswire
SVRA Bronstein, Gewirtz & Grossman LLC Announces that Savara Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MarketScreener
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Savara Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - WV News
Savara Inc. Faces Legal Battle Over MOLBREEVI Controversy - TipRanks
Portnoy Law Firm Announces Class Action on Behalf of Savara, Inc. Investors - GlobeNewswire
SVRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Savara Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
HC Wainwright Issues Optimistic Estimate for Savara Earnings - MarketBeat
Savara Inc Stock (SVRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Savara Inc Stock (SVRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
0.94%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):